A comparative study on ctDNA and tumor DNA mutations in lung cancer and benign cases with a high number of CTCs and CTECs
Abstract Background Liquid biopsy provides a non-invasive approach that enables detecting circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) using blood specimens and theoretically benefits early finding primary tumor or monitoring treatment response as well as tumor recurrence. Despit...
Main Authors: | Jianzhu Xie, Binjie Hu, Yanping Gong, Sijia He, Jun Lin, Qian Huang, Jin Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04746-8 |
Similar Items
-
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
by: Andrew A. Davis, et al.
Published: (2019-12-01) -
Case report: Post-therapeutic laryngeal carcinoma patient possessing a high ratio of aneuploid CTECs to CTCs rapidly developed de novo malignancy in pancreas
by: Jiaoping Mi, et al.
Published: (2022-09-01) -
Current status of ctDNA in precision oncology for hepatocellular carcinoma
by: Yan Li, et al.
Published: (2021-04-01) -
Choosing the Most Suitable Working Fluid for a CTEC
by: Aliet Achkienasi, et al.
Published: (2024-05-01) -
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients
by: Valerio Gristina, et al.
Published: (2024-09-01)